LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.

OBJECTIVE To explore the role of long non-coding RNA (lncRNA) HCP5 in the development of cervical cancer and its underlying mechanism. PATIENTS AND METHODS Expression levels of HCP5, MACC1 and microRNA-15a in cervical cancer tissues and paracancerous tissues were detected. The relationship between HCP5 expression and prognosis of patients with cervical cancer was analyzed by Kaplan-Meier. Cell proliferation was detected by Cell Counting Kit-8 (CCK-8) assay after altering expressions of HCP5 and microRNA-15a by plasmids transfection. The binding condition of HCP5, MACC1 and microRNA-15a was evaluated by luciferase reporter gene assay. The regulatory effect of microRNA-15a on MACC1 expression was determined by Western blot. RESULTS HCP5 and MACC1 were overexpressed in cervical cancer tissues than those of paracancerous tissues. The survival rate of patients with cervical cancer was negatively correlated to HCP5 expression, but positively correlated to microRNA-15a expression. Luciferase reporter gene assay showed that microRNA-15a was directly bound to HCP5 and MACC1. Besides, overexpression of microRNA-15a could remarkably inhibited MACC1 expression. In vitro experiments showed that HCP5 promoted proliferation of cervical cancer cells, which was reversed by microRNA-15a knockdown. CONCLUSIONS Overexpressed HCP5 promoted the development of cervical cancer through increasing MACC1 expression by microRNA-15a adsorption.

[1]  L. Zhang,et al.  Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer. , 2018, European review for medical and pharmacological sciences.

[2]  Man-man Su,et al.  Long non-coding RNAs on the stage of cervical cancer (Review). , 2017, Oncology reports.

[3]  Zhuo Xi,et al.  Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  S. Finocchario-Kessler,et al.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective , 2016, BMC Women's Health.

[5]  T. Wu,et al.  Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research , 2016, Journal of gynecologic oncology.

[6]  N. Wages,et al.  Cervical Cancer in Women Aged 35 Years and Younger. , 2016, Clinical therapeutics.

[7]  Lin Gao,et al.  Advances in long noncoding RNAs: identification, structure prediction and function annotation , 2015, Briefings in functional genomics.

[8]  F. Dieli,et al.  CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA , 2015, Molecular Cancer.

[9]  Maite Huarte,et al.  Long noncoding RNAs: from identification to functions and mechanisms , 2015 .

[10]  B. Shan,et al.  Functions of lncRNA HOTAIR in lung cancer , 2014, Journal of Hematology & Oncology.

[11]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[12]  R. Qin,et al.  Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. , 2013, Neoplasma.

[13]  Yijiang Chen,et al.  MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer , 2013, Medical Oncology.

[14]  M. Simone,et al.  MACC 1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases , 2013 .

[15]  C. MacAulay,et al.  Aberrant Expression of Long Noncoding RNAs in Cervical Intraepithelial Neoplasia , 2012, International Journal of Gynecologic Cancer.

[16]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[17]  H. Nemoto,et al.  MACC1 as a marker for advanced colorectal carcinoma. , 2010, Anticancer research.

[18]  George A Calin,et al.  MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. , 2009, Cancer research.

[19]  W. Walther,et al.  MACC1 controls Met: What a difference an Sp1 site makes , 2009, Cell cycle.

[20]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[21]  W. Birchmeier,et al.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis , 2009, Nature Medicine.

[22]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[23]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.